Controversial Alzheimer's Drug Abandoned

(MedPage Today) -- Biogen will discontinue its controversial Alzheimer's disease drug aducanumab (Aduhelm), the company announced Wednesday.
The drugmaker will stop developing and selling aducanumab, an anti-amyloid monoclonal antibody that received...

Source: MedPage Today Neurology - January 31, 2024 Category: Neurology Source Type: news